DBJ Capital vs Nippon Venture Capital
Two firms that co-invest: side by side on stage, sector, check size, and track record, from public filings and the firms' own sites.
| DBJ Capital | Nippon Venture Capital | |
|---|---|---|
| Type | Corporate VC | Venture capital |
| HQ | Tokyo | Tokyo |
| Founded | 1996 | 1996 |
| Check size | $2.7M – $354M | $1.5M – $269M |
| Stages | Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage | Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage |
| Sectors | Sector Agnostic | Biotech, Cleantech, Data & Infrastructure, EdTech, Hardware, Healthtech, Medical Devices, SaaS, Sector Agnostic |
| AUM | $4.7B | $700M |
| Tracked investments | 172 | 227 |
| Dated deals, last 24 mo | — | 1 |
Shared portfolio · 8
Cyfuse BiomedicalPerseus ProteomicsRestore VisionSymBio PharmaceuticalsUPWARD㈱エルピクセル㈱クレアトゥラ株式会社gumi 2014/12/18 東証1部へ上場
Frequently asked questions
- Do DBJ Capital and Nippon Venture Capital invest together?
- Yes — DBJ Capital and Nippon Venture Capital appear together in 8 tracked portfolio companies, including Cyfuse Biomedical, Perseus Proteomics, Restore Vision, SymBio Pharmaceuticals, UPWARD㈱.
- How do DBJ Capital and Nippon Venture Capital compare on check size?
- DBJ Capital typically writes checks of $2.7M – $354M, while Nippon Venture Capital writes $1.5M – $269M.